US Stock MarketDetailed Quotes

ETON Eton Pharmaceutical

Watchlist
  • 12.570
  • +0.290+2.36%
Close Dec 20 16:00 ET
  • 12.570
  • 0.0000.00%
Post 20:01 ET
327.47MMarket Cap-59.86P/E (TTM)

Eton Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
46.90%10.32M
-24.36%9.07M
50.19%7.97M
48.90%31.64M
-13.94%7.31M
118.33%7.03M
63.05%12M
143.75%5.3M
-2.66%21.25M
39.47%8.5M
Operating revenue
46.90%10.32M
-24.36%9.07M
50.19%7.97M
48.90%31.64M
-13.94%7.31M
118.33%7.03M
63.05%12M
143.75%5.3M
-2.66%21.25M
39.47%8.5M
Cost of revenue
53.22%4.02M
48.94%3.45M
51.12%2.96M
52.62%10.58M
72.26%3.68M
118.57%2.63M
-15.66%2.32M
130.62%1.96M
145.24%6.93M
474.73%2.14M
Gross profit
43.13%6.3M
-41.89%5.63M
49.64%5.01M
47.09%21.06M
-42.92%3.63M
118.19%4.4M
109.89%9.68M
152.15%3.35M
-24.66%14.32M
11.17%6.36M
Operating expense
17.01%5.79M
47.63%8.56M
-1.24%5.81M
-1.44%22.25M
6.13%5.62M
0.77%4.95M
-2.59%5.8M
-8.33%5.88M
10.14%22.58M
20.22%5.3M
Selling and administrative expenses
21.96%5.29M
19.62%5.59M
-3.54%5.16M
1.88%18.93M
5.10%4.58M
4.01%4.34M
-11.19%4.67M
11.45%5.35M
30.26%18.58M
16.85%4.35M
-General and administrative expense
21.96%5.29M
19.62%5.59M
-3.54%5.16M
1.88%18.93M
5.10%4.58M
4.01%4.34M
-11.19%4.67M
11.45%5.35M
30.26%18.58M
16.85%4.35M
Research and development costs
-17.89%505K
164.00%2.97M
21.68%651K
-16.87%3.32M
10.91%1.05M
-17.34%615K
63.04%1.13M
-66.93%535K
-35.91%4M
38.62%944K
Operating profit
192.88%509K
-175.59%-2.94M
68.43%-800K
85.57%-1.19M
-287.66%-1.99M
81.07%-548K
389.78%3.88M
50.19%-2.53M
-452.51%-8.26M
-19.18%1.06M
Net non-operating interest income expense
74.19%-8K
58.06%-52K
91.27%-11K
166.10%503K
622.67%784K
79.33%-31K
43.12%-124K
48.15%-126K
24.35%-761K
45.45%-150K
Non-operating interest expense
-74.19%8K
-58.06%52K
-91.27%11K
----
----
-79.33%31K
-43.12%124K
-48.15%126K
----
----
Total other finance cost
----
----
----
-166.10%-503K
----
----
----
----
-24.35%761K
----
Other net income (expense)
800K
Special income (charges)
----
----
----
--0
----
----
----
----
--0
----
-Gain on sale of property,plant,equipment
----
----
----
--0
----
----
----
----
--0
----
Other non- operating income (expenses)
----
----
----
----
----
----
--800K
----
----
----
Income before tax
186.53%501K
-165.52%-2.99M
69.51%-811K
92.36%-689K
-320.29%-2.01M
80.99%-579K
392.62%4.56M
50.09%-2.66M
-361.43%-9.02M
-12.22%912K
Income tax
-126K
54K
0
247K
247K
0
0
0
0
0
Net income
208.29%627K
-166.70%-3.04M
69.51%-811K
89.62%-936K
-347.37%-2.26M
80.99%-579K
392.62%4.56M
50.09%-2.66M
-361.43%-9.02M
-12.22%912K
Net income continuous Operations
208.29%627K
-166.70%-3.04M
69.51%-811K
89.62%-936K
-347.37%-2.26M
80.99%-579K
392.62%4.56M
50.09%-2.66M
-361.43%-9.02M
-12.22%912K
Minority interest income
Net income attributable to the parent company
208.29%627K
-166.70%-3.04M
69.51%-811K
89.62%-936K
-347.37%-2.26M
80.99%-579K
392.62%4.56M
50.09%-2.66M
-361.43%-9.02M
-12.22%912K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
208.29%627K
-166.70%-3.04M
69.51%-811K
89.62%-936K
-347.37%-2.26M
80.99%-579K
392.62%4.56M
50.09%-2.66M
-361.43%-9.02M
-12.22%912K
Basic earnings per share
200.00%0.02
-166.67%-0.12
70.00%-0.03
88.89%-0.04
-325.00%-0.09
83.33%-0.02
400.00%0.18
52.38%-0.1
-350.00%-0.36
0.00%0.04
Diluted earnings per share
200.00%0.02
-166.67%-0.12
70.00%-0.03
88.89%-0.04
-325.00%-0.09
83.33%-0.02
400.00%0.18
52.38%-0.1
-350.00%-0.36
0.00%0.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 46.90%10.32M-24.36%9.07M50.19%7.97M48.90%31.64M-13.94%7.31M118.33%7.03M63.05%12M143.75%5.3M-2.66%21.25M39.47%8.5M
Operating revenue 46.90%10.32M-24.36%9.07M50.19%7.97M48.90%31.64M-13.94%7.31M118.33%7.03M63.05%12M143.75%5.3M-2.66%21.25M39.47%8.5M
Cost of revenue 53.22%4.02M48.94%3.45M51.12%2.96M52.62%10.58M72.26%3.68M118.57%2.63M-15.66%2.32M130.62%1.96M145.24%6.93M474.73%2.14M
Gross profit 43.13%6.3M-41.89%5.63M49.64%5.01M47.09%21.06M-42.92%3.63M118.19%4.4M109.89%9.68M152.15%3.35M-24.66%14.32M11.17%6.36M
Operating expense 17.01%5.79M47.63%8.56M-1.24%5.81M-1.44%22.25M6.13%5.62M0.77%4.95M-2.59%5.8M-8.33%5.88M10.14%22.58M20.22%5.3M
Selling and administrative expenses 21.96%5.29M19.62%5.59M-3.54%5.16M1.88%18.93M5.10%4.58M4.01%4.34M-11.19%4.67M11.45%5.35M30.26%18.58M16.85%4.35M
-General and administrative expense 21.96%5.29M19.62%5.59M-3.54%5.16M1.88%18.93M5.10%4.58M4.01%4.34M-11.19%4.67M11.45%5.35M30.26%18.58M16.85%4.35M
Research and development costs -17.89%505K164.00%2.97M21.68%651K-16.87%3.32M10.91%1.05M-17.34%615K63.04%1.13M-66.93%535K-35.91%4M38.62%944K
Operating profit 192.88%509K-175.59%-2.94M68.43%-800K85.57%-1.19M-287.66%-1.99M81.07%-548K389.78%3.88M50.19%-2.53M-452.51%-8.26M-19.18%1.06M
Net non-operating interest income expense 74.19%-8K58.06%-52K91.27%-11K166.10%503K622.67%784K79.33%-31K43.12%-124K48.15%-126K24.35%-761K45.45%-150K
Non-operating interest expense -74.19%8K-58.06%52K-91.27%11K---------79.33%31K-43.12%124K-48.15%126K--------
Total other finance cost -------------166.10%-503K-----------------24.35%761K----
Other net income (expense) 800K
Special income (charges) --------------0------------------0----
-Gain on sale of property,plant,equipment --------------0------------------0----
Other non- operating income (expenses) --------------------------800K------------
Income before tax 186.53%501K-165.52%-2.99M69.51%-811K92.36%-689K-320.29%-2.01M80.99%-579K392.62%4.56M50.09%-2.66M-361.43%-9.02M-12.22%912K
Income tax -126K54K0247K247K00000
Net income 208.29%627K-166.70%-3.04M69.51%-811K89.62%-936K-347.37%-2.26M80.99%-579K392.62%4.56M50.09%-2.66M-361.43%-9.02M-12.22%912K
Net income continuous Operations 208.29%627K-166.70%-3.04M69.51%-811K89.62%-936K-347.37%-2.26M80.99%-579K392.62%4.56M50.09%-2.66M-361.43%-9.02M-12.22%912K
Minority interest income
Net income attributable to the parent company 208.29%627K-166.70%-3.04M69.51%-811K89.62%-936K-347.37%-2.26M80.99%-579K392.62%4.56M50.09%-2.66M-361.43%-9.02M-12.22%912K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 208.29%627K-166.70%-3.04M69.51%-811K89.62%-936K-347.37%-2.26M80.99%-579K392.62%4.56M50.09%-2.66M-361.43%-9.02M-12.22%912K
Basic earnings per share 200.00%0.02-166.67%-0.1270.00%-0.0388.89%-0.04-325.00%-0.0983.33%-0.02400.00%0.1852.38%-0.1-350.00%-0.360.00%0.04
Diluted earnings per share 200.00%0.02-166.67%-0.1270.00%-0.0388.89%-0.04-325.00%-0.0983.33%-0.02400.00%0.1852.38%-0.1-350.00%-0.360.00%0.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List